(Q42988157)

English

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

decision analysis

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

object named as

Michael P Manns

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Gaby Sroczynski

object named as

Gaby Sroczynski

2

1 reference

ORCID Public Data File 2021

author name string

Pamela Aidelsburger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Siegbert Rossol

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

John G McHutchison

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

John B Wong

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

341-354

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19485429%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

https://scigraph.springernature.com/pub.10.2165/00019053-200927040-00006

0 references

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927040-00006

21 January 2018

Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health an

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927040-00006

21 January 2018

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927040-00006

21 January 2018

High-priced technology can be good value for money.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927040-00006

21 January 2018

Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200927040-00006

21 January 2018

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Standard treatment of acute and chronic hepatitis C]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is severe liver disease a common outcome for people with chronic hepatitis C?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of liver transplant experience from 37 transplant centers as reported to Medicare.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for hepatitis C virus-related cirrhosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Making cost assessments based on RCTs more useful to decision-makers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markov models in medical decision making: a practical guide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lebertransplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can preference scores for discrete states be used to derive preference scores for an entire path of events? An application to prenatal diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Issues in the cross-national assessment of health technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Markov process in medical prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrosis and disease progression in hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural course of chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of combination therapy for hepatitis C: a decision analytic model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19485429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42988157&oldid=1591468448"